Metabolic syndrome over 10 years and cognitive functioning in late midlife: the Whitehall II study
- PMID: 19837794
- PMCID: PMC2797991
- DOI: 10.2337/dc09-1218
Metabolic syndrome over 10 years and cognitive functioning in late midlife: the Whitehall II study
Abstract
Objective: Evidence that the metabolic syndrome is a risk factor for poor cognition is mixed and is focused mainly on the elderly population; rarely is an adjustment made for socioeconomic factors. We examined this association in late midlife, with particular focus on cumulative effects and the role of socioeconomic circumstances.
Research design and methods: Analyses were performed for 4,150 white participants from the Whitehall II study. Metabolic syndrome, using the National Cholesterol Education Program Adult Treatment Panel III criteria, was assessed three times over the 10-year follow-up (1991-2001). Cognitive function was assessed using a battery of six tests at the end of the follow-up.
Results: After adjustment for demographic variables, health behaviors, and health status, participants with persistent metabolic syndrome (at least two of the three screenings) over the 10-year follow-up had lower cognitive performance than participants who never had metabolic syndrome. No significant differences in cognitive function were observed between participants with nonpersistent metabolic syndrome (one of the three screenings) and those who never had metabolic syndrome during the follow-up. Adjustment for adult occupational position attenuated this association by between 41 and 86%, depending on the measure of cognitive function. Adjustment for education had little effect.
Conclusions: Only persistent metabolic syndrome was associated with lower cognitive performance in late midlife. Adult occupational position but not education had a substantial impact on this association; these results highlight the importance of adult socioeconomic circumstances in identifying and targeting risk factors for cognitive aging.
Figures
Similar articles
-
Association of cognitive performance with the metabolic syndrome and with glycaemia in middle-aged and older European men: the European Male Ageing Study.Diabetes Metab Res Rev. 2010 Nov;26(8):668-76. doi: 10.1002/dmrr.1144. Diabetes Metab Res Rev. 2010. PMID: 21043047
-
Identifying the lifetime cognitive and socioeconomic antecedents of cognitive state: seven decades of follow-up in a British birth cohort study.BMJ Open. 2019 Apr 24;9(4):e024404. doi: 10.1136/bmjopen-2018-024404. BMJ Open. 2019. PMID: 31023749 Free PMC article.
-
Body mass index over the adult life course and cognition in late midlife: the Whitehall II Cohort Study.Am J Clin Nutr. 2009 Feb;89(2):601-7. doi: 10.3945/ajcn.2008.26482. Epub 2008 Dec 10. Am J Clin Nutr. 2009. PMID: 19073790 Free PMC article.
-
Impact of smoking on cognitive decline in early old age: the Whitehall II cohort study.Arch Gen Psychiatry. 2012 Jun;69(6):627-35. doi: 10.1001/archgenpsychiatry.2011.2016. Arch Gen Psychiatry. 2012. PMID: 22309970 Free PMC article.
-
Evidence of a cumulative effect of cardiometabolic disorders at midlife and subsequent cognitive function.Age Ageing. 2015 Jul;44(4):648-54. doi: 10.1093/ageing/afv053. Epub 2015 Apr 26. Age Ageing. 2015. PMID: 25918184 Clinical Trial.
Cited by
-
Metabolic Syndrome Status Changes and Cognitive Functioning: Insights from the Lifelines Cohort Study.J Prev Alzheimers Dis. 2024;11(5):1283-1290. doi: 10.14283/jpad.2024.90. J Prev Alzheimers Dis. 2024. PMID: 39350374 Free PMC article.
-
Dementia and metabolic syndrome: a bibliometric analysis.Front Aging Neurosci. 2024 Jun 12;16:1400589. doi: 10.3389/fnagi.2024.1400589. eCollection 2024. Front Aging Neurosci. 2024. PMID: 38934020 Free PMC article.
-
Metabolic Syndrome Causing Cognitive Impairment in Patients With Schizophrenia: A Systematic Review.Cureus. 2023 Oct 24;15(10):e47587. doi: 10.7759/cureus.47587. eCollection 2023 Oct. Cureus. 2023. PMID: 38022013 Free PMC article. Review.
-
Genetic Insights into the Risk of Metabolic Syndrome and Its Components on Dementia: A Mendelian Randomization.J Alzheimers Dis. 2023;96(2):725-743. doi: 10.3233/JAD-230623. J Alzheimers Dis. 2023. PMID: 37840498 Free PMC article.
-
Metabolic syndrome and cognition: A systematic review across cognitive domains and a bibliometric analysis.Front Psychol. 2022 Nov 9;13:981379. doi: 10.3389/fpsyg.2022.981379. eCollection 2022. Front Psychol. 2022. PMID: 36438337 Free PMC article.
References
-
- Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486– 2497 - PubMed
-
- Yaffe K: Metabolic syndrome and cognitive disorders: is the sum greater than its parts? Alzheimer Dis Assoc Disord 2007; 21: 167– 171 - PubMed
-
- Dik MG, Jonker C, Comijs HC, Deeg DJ, Kok A, Yaffe K, Penninx BW: Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care 2007; 30: 2655– 2660 - PubMed
-
- Komulainen P, Lakka TA, Kivipelto M, Hassinen M, Helkala EL, Haapala I, Nissinen A, Rauramaa R: Metabolic syndrome and cognitive function: a population-based follow-up study in elderly women. Dement Geriatr Cogn Disord 2007; 23: 29– 34 - PubMed
Publication types
MeSH terms
Grants and funding
- R01 HL036310/HL/NHLBI NIH HHS/United States
- G19/35/MRC_/Medical Research Council/United Kingdom
- G0100222/MRC_/Medical Research Council/United Kingdom
- AG13196/AG/NIA NIH HHS/United States
- DH_/Department of Health/United Kingdom
- G0902037/MRC_/Medical Research Council/United Kingdom
- R37 AG013196/AG/NIA NIH HHS/United States
- HL36310/HL/NHLBI NIH HHS/United States
- R01 AG013196/AG/NIA NIH HHS/United States
- HS06516/HS/AHRQ HHS/United States
- G8802774/MRC_/Medical Research Council/United Kingdom
- RG/07/008/23674/BHF_/British Heart Foundation/United Kingdom
